Work

Phase Ib venetoclax combined with bortezomib and dexamethasone in relapsed/refractory multiple myeloma.

Year: 2016

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2016.34.15_suppl.8011

Authors: Philippe Moreau, Asher Alban Akmal Chanan-Khan, Andrew Warwick Roberts, Amit Agarwal, Thierry Facon, Shaji Kumar, Cyrille Touzeau, Susan Diehl, Jaclyn Cordero, Jeremy A Ross, Wijith Munasinghe, Ming Zhu, Ahmed H. Salem, Joel Leverson, Paulo Cesar Maciag, Maria E. Verdugo, Simon J Harrison

Institutions: Centre Hospitalier Universitaire de Nantes, Mayo Clinic in Florida, The Royal Melbourne Hospital, University of Arizona, Centre Hospitalier Universitaire de Lille, Hôpital Claude Huriez, Mayo Clinic, AbbVie (United States), Peter MacCallum Cancer Centre

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2891511502

Cites:

Cited by: 4

Related to: 10